Marsh McLennan Q2 adjusted EPS $2.20, revenue $5.9B, underlying growth 11%

MARSH & MCLENNAN COMPANIES, INC.

2023-Q2 EPS reported $4.55 revenue$11,800,000,000

Q2 GAAP EPS $2.07 (+8% YoY); adjusted EPS $2.20 (+16% YoY).
Revenue $5.9B (+9% GAAP, +11% underlying); Risk & Insurance Services underlying growth 13%.
Board increased quarterly dividend 20% to $0.71/share, payable Aug 15, 2023.
Company repurchased 1.7M shares for $300M in Q2; YTD $600M on 3.5M shares.
Consulting segment underlying growth 8%; Oliver Wyman +11%, Mercer Health +10%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

MARSH & MCLENNAN COMPANIES, INC. reported the second quarter ended June 30, 2023 results: revenue $5.9 billion, net income $1.0 billion, or $2.07 per diluted share, EPS $2.20 per diluted share.

Period: the second quarter ended June 30, 2023
Revenue: $5.9 billion
Net income: $1.0 billion, or $2.07 per diluted share
EPS: $2.20 per diluted share
Result: reported results

Exact text from the filing

of our position, the value we deliver to our clients, and terrific execution by our colleagues." Consolidated Results Consolidated revenue in the second quarter of 2023 was $5.9 billion, an increase of 9% compared with the second quarter of 2022. On an underlying basis, revenue increased 11%. Operating income was $1.5 billion, an increase of 7% from a year ago.

View on SEC.gov

Browse all earnings releases →

MARSH & MCLENNAN COMPANIES, INC. filing history →

Source: SEC EDGAR

accession 0000062709-23-000072

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.